Prospective comparative study of ability of MR imaging and other imaging modalities to localize tumors in patients with Zollinger-Ellison syndrome
- 1 July 1993
- journal article
- research article
- Published by Springer Nature in Digestive Diseases and Sciences
- Vol. 38 (7) , 1318-1328
- https://doi.org/10.1007/bf01296084
Abstract
The role of magnetic resonance (MR) imaging in patients with pancreatic endocrine tumors such as Zollinger-Ellison syndrome (ZES) is controversial. In the present study we have examined the ability of current MR imaging compared with other imaging modalities, to localize gastrinomas in 43 patients with ZES. All results were subsequently assessed at exploratory laparotomy (N=34) or by liver biopsy (N=9). For the 18 patients with metastatic gastrinoma in the liver, MR imaging had a sensitivity of 83%, ultrasound 50%, CT 56%, and angiography 61%. The combination of MR imaging, ultrasound, and CT were the same as MR imaging alone. For MR imaging, both T1 and STIR sequences had equal sensitivity, although tumors were more easily seen with STIR sequences. Specificity of MR imaging was slightly lower (88%) than the other modalities (96–100%) because MR imaging incorrectly identified small hemangiomas as possible tumors in four patients. MR imaging was better than CT in identifying metastatic lesions in the liver. For the localization of primary gastrinoma, assessed in 32 patients, MR imaging had a sensitivity of 25%, ultrasound 19%, CT 28%, all three together 38%, and angiography 59%. Localization of metastatic gastrinoma in the liver or primary gastrinomas in 16 patients was assessed before and after gadolinium-DTPA (0.1 mmol/kg). The sensitivity and specificity of MR imaging was unchanged but bolus injection and rapid MR acquisition techniques were not used. These results indicate that recent advances in MR imaging have greatly improved its sensitivity for the detection and assessment of the extent of metastatic gastrinoma. MR imaging is now the imaging study of choice to assess metastatic pancreatic endocrine tumors in the liver. In contrast, the detection of primary tumors by MR imaging has not improved; therefore, angiography remains the study of choice.Keywords
This publication has 40 references indexed in Scilit:
- Curative Resection in Zollinger-Ellison Syndrome Results of a 10-Year Prospective StudyAnnals of Surgery, 1992
- Differentiation of Hepatic Hemangiomas from Metastases by Dynamic Contrast-Enhanced MR ImagingJournal of Computer Assisted Tomography, 1990
- CT and MR Imaging of Advanced Zollinger-Ellison SyndromJournal of Computer Assisted Tomography, 1989
- Intraoperative Ultrasonographic Localization of Islet Cell TumorsAnnals of Surgery, 1988
- TREATMENT OF MALIGNANT ENDOCRINE PANCREATIC TUMOURS WITH HUMAN LEUCOCYTE INTERFERONThe Lancet, 1986
- Prospective Study of Gastrinoma Localization and Resection in Patients with Zollinger-Ellison SyndromeAnnals of Surgery, 1986
- Aggressive Resection of Metastatic Disease in Selected Patients with Malignant GastrinomaAnnals of Surgery, 1986
- Contrast agents in magnetic resonance imagingClinical Radiology, 1985
- Benign and malignant gastrinomaThe American Journal of Surgery, 1985
- Results of Surgical Management in 92 Consecutive Patients with Zollinger-Ellison SyndromeAnnals of Surgery, 1981